Uridine

Uridine

SCHEMBL22129341

Nc1nc2nc[nH]c2c(=S)[nH]1.O=c1ccn([C@@H]2O[C@H](CO)[C@@H](O)[C@H]2O)c(=O)[nH]1

nearest known ligand 0.61

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

IMPDH1IMPDH2

The experimentally established mechanism targets of Uridine. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
SLC28A1 O00337 1/20 0.61
SLC28A2 O43868 1/20 0.61
SLC29A1 Q99808 1/20 0.61
SLC28A3 Q9HAS3 1/20 0.61
LMNA P02545 1/20 0.47
THRB P10828 1/20 0.47
MTOR P42345 1/20 0.47
MDM2 Q00987 1/20 0.47
NCOA1 Q15788 1/20 0.47
NCOA3 Q9Y6Q9 1/20 0.47
P2RY2 P41231 9/20 0.46
P2RY6 Q15077 8/20 0.45
P2RY14 Q15391 7/20 0.45
P2RY4 P51582 5/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Uridine SCHEMBL3345043 0.91 SLC28A1 (0.64) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Cytarabine SCHEMBL7053790 0.88 LMNA (0.65) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Uridine SCHEMBL2028411 0.86 SLC28A1 (0.65) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Uridine SCHEMBL2226523 0.85 SLC28A1 (0.56) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Guanosine SCHEMBL8024691 0.84 P2RY2 (0.56) SLC28A1SLC28A2SLC29A1SLC28A3P2RY2
Uridine SCHEMBL3351395 0.83 SLC28A1 (0.65) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Uridine SCHEMBL23243653 0.80 SLC28A1 (0.64) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Ribavirin SCHEMBL13736866 0.80 LMNA (0.64) SLC28A1SLC28A2SLC29A1SLC28A3LMNA
Thioguanine SCHEMBL16028922 0.80 PNP (0.42) LMNAMTOR
Thioguanine SCHEMBL2936430 0.80 PNP (0.42) LMNAMTOR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2020140730-A1 USE OF THIOGUANINE IN PREPARATION OF DRUG FOR TREATING ADSL DEFICIENCY 广州君赫生物科技有限公司 2020-07-09 WO disclosed
WO-2020125551-A1 APPLICATION OF THIOGUANINE IN PREPARATION OF DRUGS FOR TREATMENT, IMPROVEMENT OR PREVENTION OF TUMORS 广州君赫生物科技有限公司 2020-06-25 WO disclosed